EZH2 and breast cancer: To exclude the system interference in HP5008 cells, we conducted CRISPR-Cas9 knockouts of Rad51b, Ezh2, Suz12 and Aebp2 in Brca1-mutant 545 cells, which were isolated from a primary mammary tumor of a Brca1-MSK mouse.